Dr.Kimberly Bussey, Ph.D.

Dr. Bussey is a cancer cytogeneticist, applied bioinformatician, and an associate professor in the Precision Medicine Program. She is passionate about educating healthcare professionals about genomics and how to integrate genomics into their current medical decision making. Her research centers around understanding how large-scale chromosome alterations in tumors lead to cancer. Her motivation, the observation that cancer is an evolutionary process characterized by chromosome evolution, has led her to interdisciplinary collaborations with engineers, theoretical physicists, and artists to study both common and rare cancers in academic, government, non-profit, and industry settings. An alumna of the University of Arizona, Dr. Bussey received her PhD in Medical and Molecular Genetics from Oregon Health and Science University in 2000 and completed a post-doctoral fellowship in bioinformatics at the National Cancer Institute. She has published 40+ scientific papers and has been granted six patents for her work, with an additional two patent applications pending.

Patents:
US 9,198,910: Methods for the Treatment of Cancer

US 9,222,138: Therapeutic Targets for Adrenocortical Carcinoma

US 9,745,634: Systems and Methods for Diagnosing and Treating Cancer

US 10,066,270B2: Methods and Kits Used in Classifying Adrenocortical Carcinoma

US 11,136,614: Live Cell Methods for Microarrays

US 11,045,807: Integrated Platform for Characterization of Single Cells or Small Cell
Clusters